Insights

[Roma, 2 ottobre 2023] Hyntelo, solution provider nel campo dell'innovazione e dell'Intelligenza Artificiale, è lieta di annunciare la sua vittoria ai Digital360 Awards 2023 nella categoria CRM/Soluzioni per Marketing e Vendite, alla sua prima partecipazione. Questo prestigioso riconoscimento è stato conferito al progetto Lyriko Content Auto-Tagging, sviluppato in collaborazione con l'azienda farmaceutica Organon.

Hyntelo has again been recognized as a Sample Vendor in the Gartner “Hype Cycle for Life Science Commercial Operations, 2023” report. For the first time, Hyntelo is recognized as a Sample Vendor in “Modular Atomic Content in LS”, and for the second year as a Sample Vendor in “Advanced Decision Support for Sales”.

[Rome, 12 July 2023] Hyntelo is delighted to announce the appointment of Gianfranco Giannella as Vice Chairman and Board Member. With over 30 years of professional experience in tech-led industry transformation, Giannella brings a wealth of expertise and strategic vision to the company.

Generative AI is no longer a futuristic concept—it’s here, and it's reshaping how Pharma and Life Sciences operate. At the center of this transformation is ChatGPT, the advanced language model by OpenAI that's redefining content creation, communication, and innovation.

Hyntelo is proud to announce that it has been ranked among the 1.000 Europe’s fastest-growing companies in 2023 by Financial Times and Statista, for the third year in a row. A big achievement that confirms and recognizes the company’s commitment.

Da inizio gennaio, Luigi Cammi ha fatto il suo ingresso in Hyntelo con il ruolo di Chief Sales Officer, focalizzato nel settore Pharma & Life Science.

In today’s Pharma and Life Sciences landscape, engaging healthcare professionals (HCPs) effectively is more challenging—and more critical—than ever. That’s where Next Best Action (NBA) comes in.